Hydrochlorothiazide

Lus piav qhia luv luv:

API lub npe Qhov taw qhia Specification US DMF EU DMF CEP
Hydrochlorothiazide Diuretics USP/EP/CEP ib 16750 PIB 2006-011


Product Detail

Khoom cim npe

KHOOM PLIG

Kev piav qhia

Hydrochlorothiazide (HCTZ), ib qho tshuaj diuretic ntawm qhov ncauj ntawm chav kawm thiazide, inhibits kev hloov TGF-β/Smad signaling txoj kev.Hydrochlorothiazide muaj cov nyhuv ncaj qha vascular relaxant los ntawm kev qhib cov calcium-activated potassium (KCA) channel.Hydrochlorothiazide txhim kho lub plawv ua haujlwm, txo cov fibrosis thiab muaj cov nyhuv antihypertensive.

Keeb kwm

Hydrochlorothiazide yog cov tshuaj diuretic ntawm chav kawm thiazide.

Hauv Vitro

Hydrochlorothiazide belongs rau thiazide chav kawm ntawm diuretics.Nws txo cov ntshav ntim los ntawm kev ua haujlwm ntawm lub raum kom txo cov sodium (Na) reabsorption hauv lub distal convoluted tubule.Qhov chaw loj ntawm kev ua hauv nephron tshwm rau ntawm ib qho electroneutral Na +-Cl co-transporter los ntawm kev sib tw rau qhov chaw chloride ntawm lub transporter.Los ntawm impairing Na thauj nyob rau hauv lub distal convoluted tubule, hydrochlorothiazide induces ib natriuresis thiab concomitant dej poob.Thiazides ua rau kom cov calcium reabsorption nyob rau hauv ntu no nyob rau hauv ib yam uas tsis cuam tshuam rau sodium thauj.Tsis tas li ntawd, los ntawm lwm cov txheej txheem, Hydrochlorothiazide ntseeg tias txo qis peripheral vascular tsis kam.

Hydrochlorothiazide (HCTZ; qhov ncauj bygavage; 12.5 mg / kg / d; 8 lub lis piam) tau txhim kho lub plawv ua haujlwm, txo qis plawv interstitial fibrosis thiab collagen ntim feem, txo qis ntawm AT1, TGF-β thiab Smad2 nyob rau hauv cov ntaub so ntswg plawv hauv cov txiv neej laus Sprague Dawley nas.Tsis tas li ntawd, hydrochlorothiazide txo plasma angiotensin II thiab aldosterone qib.Tsis tas li ntawd, hydrochlorothiazide inhibits angiotensin II-induced TGF-β1 thiab Smad2 protein qhia nyob rau hauv neonatal nas ventricular fibroblasts.

Cov qauv tshuaj

Hydrochlorothiazide

CERTIFICATE

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

QUALITY MANAGEMENT

Quality management1

Tswv yim18Quality Consistency Evaluation tej yaam num uas tau pom zoo4, thiab6tej yaam num raug tso cai.

Quality management2

Advanced thoob ntiaj teb kev tswj hwm qhov system tau tso lub hauv paus ruaj khov rau kev muag khoom.

Quality management3

Kev saib xyuas zoo ua haujlwm los ntawm tag nrho lub neej voj voog ntawm cov khoom kom ntseeg tau tias qhov zoo thiab kho cov nyhuv.

Quality management4

Pab Pawg Kev Tswj Xyuas Kev Tswj Xyuas Kev Ua Haujlwm txhawb nqa qhov kev xav tau zoo thaum lub sijhawm thov thiab tso npe.

PRODUCTION MANAGEMENT

cpf5
cpf6

Kauslim Countec Lub raj mis ntim kab

cpf7
cpf8

Taiwan CVC Lub raj mis ntim kab

cpf9
cpf10

Ltalis CAM Board Ntim Kab

cpf11

German Fette Compacting Tshuab

cpf12

Nyiv Viswill Tablet Detector

cpf14-1

DCS Control Room

PARTNER

Kev koom tes thoob ntiaj teb
International cooperation
Kev koom tes hauv tsev
Domestic cooperation

  • Yav dhau los:
  • Tom ntej:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb

    Cov khoom qeb